The WACC of Nektar Therapeutics (NKTR) is 7.1%.
| Range | Selected | |
| Cost of equity | 7.40% - 10.90% | 9.15% |
| Tax rate | 0.10% - 0.10% | 0.10% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 6.2% - 8.0% | 7.1% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.77 | 1.09 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.40% | 10.90% |
| Tax rate | 0.10% | 0.10% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 6.2% | 8.0% |
| Selected WACC | 7.1% | |